Evidence map›Paper›PMID 32193584›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2020

IL-18/IL-18R1 promotes circulating fibrocyte differentiation in the aging population.

Xiao-Hui Niu, Yun-Peng Xie, Song Yang, Yanchun Chen, Liang Xu, Ying Zhang, Yang Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Circulating Fibrocytes: Cellular Mediators of Tissue Fibrosis.International journal of molecular sciences · 2026
    Review
  2. Review
  3. Mechanisms and Therapeutic Potential of Myofibroblast Transformation in Pulmonary Fibrosis.Journal of respiratory biology and translational medicine · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Xiao-Hui NiuInstitute of Cardiovascular Diseases, The First Affiliated Hospital of Dalian Medical University, No 222, Zhongshan Rd, Dalian, China.
Yun-Peng XieInstitute of Cardiovascular Diseases, The First Affiliated Hospital of Dalian Medical University, No 222, Zhongshan Rd, Dalian, China.
Song YangYixing People's Hospital, The Affiliated Hospital of Jiangsu University, Yixing, China.
Yanchun ChenYixing People's Hospital, The Affiliated Hospital of Jiangsu University, Yixing, China.
Liang XuYixing People's Hospital, The Affiliated Hospital of Jiangsu University, Yixing, China.
Ying ZhangDepartment of Cardiology, the First Affiliated Hospital of Dalian Medical University, No 222, Zhongshan Rd, Dalian, China. zy114129@sina.com.
Yang LiuInstitute of Cardiovascular Diseases, The First Affiliated Hospital of Dalian Medical University, No 222, Zhongshan Rd, Dalian, China. liuyang19831119@163.com.
Jiangsu University · CNFirst Affiliated Hospital of Dalian Medical University · CNAffiliated Hospital of Jiangsu University · CNDalian Medical University · CN

Funding

Jiangsu University JLY20180073Scientific Research Project of Education Department of Liaoning Province LZ2019017Scientific Research Project of Education Department of Liaoning Province LZ2019021
6 · The paper itself

Abstract

backgroundFibrosis in multiple organs increases with age. Circulating fibrocytes are bone-marrow-derived mesenchymal progenitors that contribute to heart, lung, and kidney fibrosis under the diseased conditions. Whether circulating fibrocytes contribute to aging-related fibrosis is very limited. METHODS AND

resultsWe measured the proportion and differentiation of circulating fibrocytes (CD45

conclusionCirculating fibrocytes from elders had an enhanced capacity to differentiate into myofibroblasts, and might contribute to age-dependent fibrosis. Age-dependent increment of differentiation at least in part arose from their enhanced expression of IL-18R1. Inhibiting fibrocyte differentiation might be useful as an adjuvant treatment to delay the fibrosis process in aging population.

Indexed as

AgingInterleukin-18Interleukin-18 Receptor alpha SubunitAdolescentAdultAgedCell DifferentiationCollagen Type ICollagen Type IICytokinesFemaleFibroblastsFlow CytometryHumansMaleMiddle AgedCollagen Type ICollagen Type IICytokinesIL18 protein, humanIL18R1 protein, humanInterleukin-18Interleukin-18 Receptor alpha SubunitAgingCirculating fibrocytesFibrosisIL-18IL-18R1

Identifiers

PMID32193584
OpenAlexW3012190907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.